In a study by Wang et al., the F56-peptide-fused nanoparticles loaded with vincristine (F56-VCR-NP) were able to target both neovasculature and primary lesions of lung metastases, leading to neovasculature apoptosis and CRC tissue destruction [132]
Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, Bolaos-Salazar JF, Muoz-Atahualpa E, Postigo-MacDowall M, Corrales-Medina F, Valdivia-Ascua Z, Cuba-Bustinza C, Paredes-Daz S, Villalobos-Tapia P, Chirinos-Pacheco J, Goldberg RB, Chirinos JA
Scientists have been studying its potential in various health applications, from tissue repair to brain function enhancement
Not a medicine, not evaluated by BPOM, and not for human or veterinary consumption